ClinicalTrials.gov
ClinicalTrials.gov Menu

Belimumab in Remission of VASculitis (BREVAS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01663623
Recruitment Status : Completed
First Posted : August 13, 2012
Last Update Posted : November 29, 2017
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by (Responsible Party):
GlaxoSmithKline ( Human Genome Sciences Inc., a GSK Company )

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : February 6, 2017
  Actual Study Completion Date : February 6, 2017